PREDICTRX Trademark

Trademark Overview

On Monday, November 27, 2017, a trademark application was filed for PREDICTRX with the United States Patent and Trademark Office. The USPTO has given the PREDICTRX trademark a serial number of 79229729. The federal status of this trademark filing is ABANDONED - AFTER INTER-PARTES DECISION as of Friday, March 15, 2019. This trademark is owned by Imagen Therapeutics Limited. The PREDICTRX trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Medical analysis services for cancer prognosis and treatment; medical testing services, namely, the testing of cells to optimise treatment for cancer; providing medical information to patients and medical professionals in the form of reports relating to the testing of cancer cells and the treatment of cancer; information, advisory and consultancy services in relation to the aforesaid

General Information

Serial Number79229729
Word MarkPREDICTRX
Filing DateMonday, November 27, 2017
Status604 - ABANDONED - AFTER INTER-PARTES DECISION
Status DateFriday, March 15, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 27, 2018

Trademark Statements

Pseudo MarkPREDICT RX
Goods and ServicesMedical analysis services for cancer prognosis and treatment; medical testing services, namely, the testing of cells to optimise treatment for cancer; providing medical information to patients and medical professionals in the form of reports relating to the testing of cancer cells and the treatment of cancer; information, advisory and consultancy services in relation to the aforesaid

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code8 - Abandoned
Class Status DateFriday, March 15, 2019
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameImagen Therapeutics Limited
Party Type20 - Owner at Publication
Legal Entity Type24 - NOT AVAILABLE
AddressGB
Party NameImagen Therapeutics Limited
Party Type10 - Original Applicant
Legal Entity Type24 - NOT AVAILABLE
AddressGB

Trademark Events

Event DateEvent Description
Friday, November 11, 2022NEW REPRESENTATIVE AT IB RECEIVED
Friday, April 3, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, March 16, 2020FINAL DISPOSITION NOTICE SENT TO IB
Sunday, March 15, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, March 15, 2019ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION
Friday, March 15, 2019ABANDONMENT - AFTER INTER PARTES DECISION
Friday, March 15, 2019OPPOSITION TERMINATED NO. 999999
Friday, March 15, 2019OPPOSITION SUSTAINED NO. 999999
Friday, December 28, 2018REFUSAL PROCESSED BY IB
Thursday, December 6, 2018OPPOSITION INSTITUTED NO. 999999
Tuesday, December 4, 2018OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
Tuesday, December 4, 2018OPPOSITION NOTICE (IB REFUSAL) CREATED
Monday, December 3, 2018OPPOSITION PAPERS RECEIVED AT TTAB
Tuesday, November 27, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 27, 2018PUBLISHED FOR OPPOSITION
Saturday, November 24, 2018NOTIFICATION PROCESSED BY IB
Wednesday, November 7, 2018NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, November 7, 2018NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, November 7, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 16, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 16, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 16, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 15, 2018ASSIGNED TO LIE
Tuesday, October 2, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, May 4, 2018REFUSAL PROCESSED BY IB
Monday, April 16, 2018NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, April 16, 2018REFUSAL PROCESSED BY MPU
Thursday, April 12, 2018NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, April 11, 2018NON-FINAL ACTION WRITTEN
Tuesday, April 10, 2018APPLICATION FILING RECEIPT MAILED
Friday, April 6, 2018ASSIGNED TO EXAMINER
Friday, April 6, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, April 5, 2018SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

predictrx cancer medical treatment testing services information cells relating reports form